Similarly, levels of SPON2, an ECM protein involved in innate immunity, correlate with DN severity in T2DM patients 45; we observed increased Spon2 levels in the diabetic kidney that were reversed by pioglitazone treatment. Here, SPON2 is linked to liver dysplastic nodule.